FAGR Fagron SA

Fagron publishes annual report 2023

Fagron publishes annual report 2023

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 14 March 2024 – 6:30 PM CET

Fagron publishes annual report 2023

Fagron, the leading global player in pharmaceutical compounding, today publishes its annual report 2023. Discussion of the annual report and the approval of the financial statements will be put on the agenda of the annual general meeting of shareholders scheduled for 13 May 2024.

The annual report is available in the official Dutch version and in English translation on Fagron’s .

Further information

Karen Berg

Global Investor Relations Manager

Tel. 99

About Fagron

Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.

Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

Attachment



EN
14/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

 PRESS RELEASE

Disclosure of notification received from Mawer

Disclosure of notification received from Mawer Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 5 September 2025 – 5:40 PM CET Disclosure of notification received from Mawer Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a notification from Mawer. Notification by Mawer Investment Management Ltd On 3 September 2025, Fagron received a notification that the shareholding of Mawer Investment Management Ltd, crossed the disclosure threshold of 5% downwards on 29 August 2025 as the result of t...

 PRESS RELEASE

Openbaarmaking van kennisgeving ontvangen van Mawer

Openbaarmaking van kennisgeving ontvangen van Mawer Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 5 september 2025 – 17u40 CET Openbaarmaking van kennisgeving ontvangen van Mawer Fagron heeft een kennisgeving ontvangen op grond van de Belgische Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in beursgenoteerde vennootschappen van Mawer. Kennisgeving van Mawer Investment Management Ltd Op 3 september 2025 ontving Fagron een melding dat het belang van Mawer Investment Management Ltd de meldingsdrempel van 5% had overschreden op 29 augustus 2025...

Robert Jan Vos ... (+2)
  • Robert Jan Vos
  • Usama Tariq

ResearchPool Subscriptions

Get the most out of your insights

Get in touch